Cancer Prevention

Genetic risk profiles and biomarkers in cancer prevention: Progress in cancer prevention and screening. Genetic risk profiles for cancer susceptibility and therapy response. Tumor promotion as a target of cancer prevention. Insulin-like growth factor-related signaling and cancer development. Inflammation, infection, and cancer prevention: Cytokines are a therapeutic target for the prevention of inflammation-induced cancers. Prevention of hepatocellular carcinoma in chronic viral hepatitis patients with cirrhosis by carotenoid mixture. Cox-2 and cancer chemoprevention.- Prevention of female and male genital cancers: Human Papillomavirus vaccine: a new chance to prevent cervical cancer. Prevention and early detection of ovarian cancer. Prevention of prostate cancer. Primary prevention of breast cancer by hormone-induced differentiation.- Prevention of breast cancer: The genomic signature of breast cancer prevention. Estrogen deprivation for breast cancer prevention.- Prevention of colorectal and renal cancers: Primary dietary prevention. Prevention and early detection of colorectal cancer.- Prevention of skin, brain, and lung tumors: New perspectives on melanoma pathogenesis and chemoprevention. Vitamin D – an emerging issue in skin cancer control. Implications for public health practice based on the Australian experience. Are gliomas preventable?- The future of cancer (chemo)prevention: Angiogenesis and cancer prevention. An estimate of cancer mortality rate reductions in Europe and the US with 1,000 IU of oral vitamin D per day. Uncovering novel targets for cancer chemoprevention.- Conference summary.